Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Obese women with PCOS are more likely to have fatty liver disease.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Quercetin may help with PCOS symptoms, but more research is needed.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Too much thymosin beta4 causes weird teeth and more hair growth in mice.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.